VAD Chemotherapy versus Bortezomib Containing Regimens as Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience.
Int J Hematol Oncol Stem Cell Res
; 14(4): 248-256, 2020 Oct 01.
Article
in En
| MEDLINE
| ID: mdl-33603986
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
Language:
En
Journal:
Int J Hematol Oncol Stem Cell Res
Year:
2020
Document type:
Article
Affiliation country:
Turkey
Country of publication:
Iran